Radiation Treatment Plan Evaluation Learning Tool Pilot Project

Sponsor

Massachusetts General Hospital (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT06115811

Collaborator

(none)

Enrollment

Location

Arm

Anticipated Duration (Months)

0.9

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this tool as an effective resource to teach treatment plan review and optimization to radiation oncology residents.

Condition or Disease	Intervention/Treatment	Phase
Radiation Oncology	Behavioral: Radiation Treatment Plan Evaluation Learning Tool	N/A

Detailed Description

Stud procedures include screening for eligibility and completion of surveys and oncology examinations.

Participation is expected to last about 6-8 weeks.

It is expected about 20 radiation oncology resident physicians will participate in the study.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

20 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Other

Official Title:

Development and Assessment of a Novel, Systematic Radiation Treatment Plan Evaluation Learning Tool for Radiation Oncology Residents

Anticipated Study Start Date :

Nov 1, 2023

Anticipated Primary Completion Date :

Sep 1, 2024

Anticipated Study Completion Date :

Sep 1, 2025

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Radiation Treatment Plan Evaluation Learning Module Radiation oncology resident physicians will complete study procedures as below: Initial survey and pre-module examination. Learning module. Post-module survey and examination.	Behavioral: Radiation Treatment Plan Evaluation Learning Tool Web-based program comprised of a systematic, oncology treatment plan review system and learning modules. The case bank of radiation treatments plans is accessible via econtour.org.

Arm

Intervention/Treatment

Experimental: Radiation Treatment Plan Evaluation Learning Module

Radiation oncology resident physicians will complete study procedures as below: Initial survey and pre-module examination. Learning module. Post-module survey and examination.

Behavioral: Radiation Treatment Plan Evaluation Learning Tool

Web-based program comprised of a systematic, oncology treatment plan review system and learning modules. The case bank of radiation treatments plans is accessible via econtour.org.

Outcome Measures

Primary Outcome Measures

Objective Examination Score [Up to 8 weeks]
Analyzed with a paired samples t-test.

Secondary Outcome Measures

Oncology Resident Confidence Rate [Week 1 - 8]
Scored using Likert scales and analyzed with non-parametric tests.
Oncology Resident Perceived Competence Rate [Week 1 - 8]
Scored using Likert scales and analyzed with non-parametric tests.

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

The pilot program will be open to radiation oncology resident physicians that are in their PGY-2, PGY-3, or PGY-4 year.
All residents must have completed a breast cancer-specific radiation oncology rotation at least 3 months prior to enrollment in the pilot program in order to be eligible.

Exclusion Criteria:

-The study will not include any special populations.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Massachusetts General Hospital Cancer Center	Boston	Massachusetts	United States	02215

Sponsors and Collaborators

Massachusetts General Hospital

Investigators

Principal Investigator: Rachel Jimenez, MD, Massachusetts General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Rachel Beth Jimenez, Principal Investigator, Massachusetts General Hospital

ClinicalTrials.gov Identifier:

NCT06115811

Other Study ID Numbers:

23-021

First Posted:

Nov 3, 2023

Last Update Posted:

Nov 3, 2023

Last Verified:

Oct 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Rachel Beth Jimenez, Principal Investigator, Massachusetts General Hospital

Radiation Oncology

Education

Additional relevant MeSH terms:

Neoplasms

Study Results

No Results Posted as of Nov 3, 2023